The management of Zydus Life also reiterated that they are on track to achieve their financial year 2025 goal of double-digit growth across their key businesses, coupled with improved profitability.
Zydus Lifesciences Q3 Results: US formulation sales near $300 million, forex gains aid profit
Share it
Related Article
